Join the Delatestryl group to help and get support from people like you.
Delatestryl News
Testosterone Therapy Doesn't Increase Cancer Risk For Transmasculine People
FRIDAY, May 16, 2025 — Transmasculine and gender diverse people who use testosterone are not at an increased risk for cervical, ovarian or other gynecological cancers, a new study says. The results s...
Testosterone Tied to Incidence, Progression of Metabolic Syndrome
THURSDAY, July 11, 2024 – Testosterone is associated with a greater risk for development and progression of metabolic syndrome, particularly in transmasculine individuals, according to a study...
Male Birth Control Gel Shows Promise in Trial
MONDAY, June 3, 2024 – A new hormonal gel could one day be a potential form of birth control for men, researchers reported Sunday. “The development of a safe, highly effective and reliably r...
FDA Medwatch Alert: FDA Alerts Customers to Voluntary Recall of Compounded Drugs Due to Sterility Issues by Drug Depot, LLC, dba APS Pharmacy
April 26, 2022 --FDA is alerting patients, health care professionals, veterinarians, and animal owners/caretakers about a voluntary recall by Drug Depot, LLC, doing business as APS Pharmacy, of...
FDA Medwatch Alert: Testosterone and Other Anabolic Androgenic Steroids (AAS): FDA Statement - Risks Associated With Abuse and Dependence
ISSUE: FDA approved class-wide labeling changes for all prescription testosterone products, adding a new Warning and updating the Abuse and Dependence section to include new safety information from...
FDA Medwatch Alert: Testosterone Products: FDA/CDER Statement - Risk of Venous Blood Clots
[Posted 06/20/2014] ISSUE: FDA notified health professionals and their medical care organizations that it is requiring the manufacturers of all approved testosterone products to include a warning ...
FDA Medwatch Alert: Testosterone Products: Drug Safety Communication - FDA Investigating Risk of Cardiovascular Events
[Posted 01/31/2014] ISSUE: FDA is investigating the risk of stroke, heart attack, and death in men taking FDA-approved testosterone products. We have been monitoring this risk and decided to...
FDA Medwatch Alert: University Compounding Pharmacy Injection Products: Recall - Lack of Sterility Assurance
ISSUE: University Compounding Pharmacy is voluntarily recalling products, including Testosterone Cypionate (Sesame Oil), Testosterone Cypionate/Testosterone Proprionate, and PGE-1 NS, for injection, ...
FDA Medwatch Alert: Olympia Pharmacy Sterile Compounded Products: Recall - Concerns About Sterility Assurance
[Posted 05/30/2013] ISSUE: Lowlite Investments d/b/a Olympia Pharmacy ("Lowlite") notified the public of a voluntary multi-state recall of all sterile drug products compounded by the pharmacy that ...